JCHOR
Journal of Current Hematology & Oncology Research

The Journal of Current Hematology & Oncology Research regularly publishes internationally qualified research in hematology and oncology within the current scholarly knowledge.

eISSN: 2980-0854
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Case Report
A rare case of olfactory neuroblastoma
Abstract
Olfactory neuroblastoma, also referred to as esthesioneuroblastoma, is a rare malignancy of the nasal cavity with an incidence of approximately 0.4 per million individuals. The most frequently encountered symptom is nasal obstruction, though patients may also present with epistaxis and nasal discharge. Management strategies primarily involve surgical resection and radiotherapy, while the role of chemotherapy remains limited. Currently, there is no universally accepted treatment protocol for this condition. This report describes a case of olfactory neuroblastoma staged as Kadish stage C, in which the patient underwent chemoradiotherapy. Follow-up imaging revealed no evidence of disease recurrence. This case suggests that chemotherapy may have a role in the treatment regimen for advanced-stage olfactory neuroblastoma, potentially enhancing therapeutic outcomes in such cases.

Keywords : Olfactory neuroblastoma, chemotherapy, radiotherapy

Download Article


1. Ward PD, Heth JA, Thompson BG, Marentette LJ. Esthesioneuroblastoma: results and outcomes of a single institution's experience. Skull Base. 2009; 19(2):133-140.
2. Batchu S, Gill AS, Karsy M. Characterizing immune infiltration in esthesioneuroblastoma subtypes through gene expression deconvolution. World Neurosurg. 2024;183:e928-e935.
3. Kuan EC, Nasser HB, Carey RM, et al. A population-based analysis of nodal metastases in esthesioneuroblastomas of the sinonasal tract. Laryngoscope. 2019;129(5):1025-1029.
4. Gabbay U, Leider-Trejo L, Marshak G, Gabbay M, Fliss DM. A case and a series of published cases of esthesioneuroblastoma (ENB) in which long-standing paraneoplastic SIADH had preceded ENB diagnosis. Ear Nose Throat J. 2013;92(10-11):E6.
5. Chamberlain MC. Treatment of intracranial metastatic esthesioneuroblastoma. Cancer. 2002;95(2):243-248.
6. Weiden PL, Yarington CT, Richardson RG. Olfactory neuroblastoma: chemotherapy and radiotherapy for extensive disease. Arch Otolaryngol. 1984;110(11):759-760.
7. Gay LM, Kim S, Fedorchak K, et al. Comprehensive genomic profiling of esthesioneuroblastoma reveals additional treatment options. Oncologist. 2017;22(7):834-842.
8. Kadish S, Goodman M, Wang C. Olfactory neuroblastoma-a clinical analysis of 17 cases. Cancer. 1976;37(3):1571-1576.
9. Cranmer LD, Chau B, Rockhill JK, Ferreira M, Liao JJ. Chemotherapy in esthesioneuroblastoma/olfactory neuroblastoma: an analysis of the Surveillance Epidemiology and End Results (SEER) 1973-2015 database. Am J Clin Oncol. 2020;43(3):203-209.
10. Eich HT, Hero B, Staar S, et al. Multimodality therapy including radiotherapy and chemotherapy improves event-free survival in stage C esthesioneuroblastoma. Strahlenther Onkol. 2003;179(4):233-240.
11. Fitzek MM, Thornton AF, Varvares M, et al. Neuroendocrine tumors of the sinonasal tract: results of a prospective study incorporating chemotherapy, surgery, and combined proton-photon radiotherapy. Cancer. 2002;94(10):2623-2634.
12. Miller KC, Marinelli JP, Van Gompel JJ, et al. Utility of adjuvant chemotherapy in patients receiving surgery and adjuvant radiotherapy for primary treatment of esthesioneuroblastoma. Head Neck. 2019;41(5):1335-1341.
Article available in :
Volume 2, Issue 4, 2024
Page : 98-99
https://doi.org/10.51271/JCHOR-0049
Article Information
Received : 02 Aug 2024
Accepted : 13 Sep 2024
Published : 14 Nov 2024
Corresponding Author :

Salih Karatlı: Department of Medical Oncology, Ankara Etlik City Hospital, Ankara, Turkiye

[email protected]
Citation : Karatlı S, Kavak EE. A rare case of olfactory neuroblastoma. J Curr Hematol Oncol Res. 2024;2(4):98-99.

Read: 1179
Download : 1599
Cited: 0
_Footer